A client with plaque psoriasis is scheduled to start deucravacitinib. Which finding requires clarification before the first dose?

1 The client completed a nonlive influenza vaccine last month.
2 The client plans to take the tablet with breakfast.
3 The client has untreated latent tuberculosis and is scheduled to receive a live vaccine next week. ✓ Correct answer
4 The client uses fragrance-free moisturizer for dry skin.

Explanation

Before deucravacitinib, the client requires evaluation for tuberculosis and completion of appropriate immunizations. Active tuberculosis is a stop condition, latent infection needs treatment planning, and live vaccines should be avoided during therapy.

Next question on this topicA nurse is reviewing the morning lab results for an adult client receiving warfarin for at…

In-depth explanation

Quick answer
Clarify untreated tuberculosis risk and a planned live vaccine before deucravacitinib.

Why this is correct
TYK2 inhibition can increase infection risk. Screening and preventive planning occur before immunomodulation; food timing and routine skin care do not create the same immediate safety conflict.

Easy analogy or mental picture
Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.

Memory hook
Drug, urgent cue, protective action, and reassessment endpoint.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.

Why the other choices are wrong
Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.

References

1DailyMed: SOTYKTU (deucravacitinib)Infection and tuberculosis screening, serious-infection interruption, immunization planning, and avoidance of live vaccines

Clinical scenario

Medication-safety review
Verify indication, current assessment, dose and route, organ function, interactions, urgent toxicity cues, authorized action, and measurable follow-up.

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free

App Store Google Play

Read in another language: English 한국어 日本語繁體中文 Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.

성장을 멈추지 마세요

A client with plaque psoriasis is scheduled to start deucravacitinib. Which finding requires clarification before the first dose?

In-depth explanation

Clinical scenario

Master the NCLEX-RN with MyMerci